...read the wave

Nano Biz...in depth... im detail


Next Generation Biological Detection System Developed by ANP Technologies Leverages Cogent Systems' ASIC and Pattern Recognition Technology

NEWARK, Del. & SOUTH PASADENA, Calif.--(BUSINESS WIRE)--March 2, 2005

ANP Technologies, Inc., a leading prime contractor for the U.S. Army, specializing in nanobiotechnology, today announced its partnership with Cogent Systems (Nasdaq:COGT) in developing a low-cost, rapid biological detection system. ANP Technologies has developed a next generation Nano-Intelligent Detection System (NIDS(TM)) based low-cost, rapid, multiplexed assay for the identification and quantitative analysis of various biological agents and biomarkers to the U.S. Government and pharmaceutical industries.

Utilizing Cogent's cutting-edge miniaturized ASIC, which includes the Dimensional Digital Signal Processor (D2SP) and its innovative pattern recognition algorithm, ANP has recently constructed a detection system for the identification and quantification of various biological agents including B. anthracis spores and botulinum toxin, as well as biomarkers related to certain diseases or disease states. In addition, Cogent provides integration of automated data management and data mining software. The initial contract value is for $500,000.

The assay and detection system will be initially utilized by leading Department of Defense programs and agencies such as the Joint Service Agent Water Monitor (JSAWM) program, Walter Reed Army Institute of Research (WRAIR), and Naval Medical Research Center (NMRC). NIDS(TM) provides the throughput, cost effectiveness and flexibility necessary for military personnel in the battlefield for both "Detect to Warn" and "Detect to Treat" purposes.

"Our revolutionary biological detection system, which combines our patented nanobiotechnology and Cogent's state-of-the-art pattern recognition technology, dramatically cuts down the response time for detecting biological agents at a fraction of the cost," commented Tom Bodnar, VP for Business Operations at ANP Technologies. "This same system has vast potential to revolutionize translational medicine by enabling scientists, both in the life sciences and pharmaceuticals industries, to literally perform billions of experiments utilizing less time and reagents to produce similar results relative to technologies in existence today, thereby providing valuable medical information from which to extend their research efforts. This technology has the capability to extend into personalized medicine by providing rapid diagnostic results, correlating drug efficacies within specific patient groups through protein profiling, and enabling better choices of drugs for individual patients."

"We are excited to work with ANP Technologies on such a revolutionary program and believe it offers tangible evidence of the applicability of our technology across multiple industries," commented Ming Hsieh, President and Chief Executive Officer of Cogent. "Our detection system leverages the power of our ASIC technology and our pattern recognition software to deliver a much more powerful and cost-effective solution. We are seeing increasing opportunities like this to leverage our biometric technology into promising growth areas."

About ANP Technologies, Inc.

ANP Technologies is a leading provider of nanobiotechnology based products for biodefense, drug discovery, translational medicine, point of care diagnostics, therapeutic effect monitoring, and drug delivery. ANP's mission is to develop cutting-edge technology platforms at the nano/bio interface and market them to the U.S. Government and large pharmaceutical/biotechnology companies. Founded in 2002, ANP is headquartered in Newark, Delaware and has received numerous government contracts, grants, awards and commercial contracts that has allowed for complete organic growth and profitability throughout its existence as a privately-held corporation. Additional information about ANP Technologies can be found at www.anptinc.com.

About Cogent Systems, Inc.

Cogent is a leading provider of Automated Fingerprint Identification Systems, or AFIS, and other fingerprint biometric solutions to governments, law enforcement agencies and other organizations worldwide. Cogent's AFIS solutions enable customers to capture fingerprint images electronically, encode fingerprints into searchable files and accurately compare a set of fingerprints to a database containing potentially millions of fingerprints in seconds.

NOTE : In the product name mentioned in this release, Dimensional Digital Signal Processor (D2SP), the 2 should be superscript. This symbol may not appear properly in some systems.


The Blueshirt Group (for Cogent)
Chris Danne, 415-217-7722
Rakesh Mehta, 415-217-7722
ANP Technologies
Thomas Bodnar, 302-283-1730

This story has been adapted from a news release -
Diese Meldung basiert auf einer Pressemitteilung -
Deze tekst is gebaseerd op een nieuwsbericht -


who is reading
the wave ?

missed some news ?
click on archive photo


or how about joining us


or contacting us ?


about us


our mission